For instance, we have predicted specific interactions between tumor-enriched angiogenic ECs and subtypes of CD8+ T cells or Macrophage cells, which may hold implications for tumor angiogenesis in different subtypes of BC. This evidence concerns the gene CD8A and neoplasm.